AGP Executive Report
Last update: 7 hours agoCancer Research: Spain highlighted its growing oncology role ahead of the ESMO congress in Madrid: 378 of the 962 clinical trials launched in the country last year focused on cancer. Digestive Health: At UEG Week in Barcelona, a Phase III trial found Tezspire improved swallowing symptoms and tissue inflammation in people with eosinophilic oesophagitis; benefits persisted to week 52. Screening: A large randomized study presented at the same congress suggests people at low risk of colorectal cancer could repeat stool tests every three years instead of every two, though longer follow-up is needed to confirm safety. Heart Care: A new EU-backed research project will run 22 studies involving more than 14,000 patients across 17 countries, testing earlier and more personalized cardiovascular care. Weight Management: US telehealth firm Hims & Hers has launched an online weight-management service for men in Germany, with eligible patients able to access clinician-prescribed treatment; medicines are often not covered by insurance.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
